BOB体育

Skip to main content

Frank A Orlando, MD, FAAFP

Family Doctor

Photo of Frank A Orlando

Research at a glance

Top areas of exploration

  • COVID-19 , 2 publications
  • Anti-Bacterial Agents , 2 publications
  • Family Practice , 2 publications
  • Adipose Tissue , 2 publications

Research activity

32 publications

263 citations

Why is this important?

Focus

Family Medicine offers ample opportunity to simultaneously research numerous topics, and my current areas of research interest are COVID-19, wellness (including body composition & obesity management), cardiovascular disease (CVD), genetics/pharmacogenetics, addiction/chronic pain management, and social determinants of health. I have currently accumulated 7% time as Co-Investigator on a mobile health smoking cessation study and a clinical trial on the potential of kava in enabling smoking cessation. I am Site Principal Investigator on a grant called Cardiovascular Track pending NIH submission. CVD continues to be the greatest cause of disease burden in the US and worldwide, and national surveillance tools effectively monitor behaviors or outcomes related to CVD, but not both. CVH Track is a multi-institutional research initiative including UF OneFlorida to build a complex, modern surveillance system using real world data from the PCORnet Common Data Model and regular, modular behavioral surveys designed to track changes in behavior and outcomes that impact risk for CVD development, over time.

My publications

32 publications

2023

Peritonitis (secondary)

Essential Evidence Plus

2022

Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD

The Journal of Clinical Endocrinology & Metabolism

鈥�

2022

Appraising Important Medical Literature Biases: Uncorrected Statistical Mistakes and Conflicts of Interest

Frontiers in Medicine

鈥�

2022

The Impact of Initial COVID-19 Episode Inflammation Among Adults on Mortality Within 12 Months Post-hospital Discharge.

Frontiers in medicine

鈥�

2021

COVID-19 Post-acute Sequelae Among Adults: 12 Month Mortality Risk.

Frontiers in medicine

鈥�